Abstract:Motivation Accurate identification of peptides binding to specific Major Histocompatibility Complex Class II (MHC-II) molecules is of great importance for elucidating the underlying mechanism of immune recognition, as well as for developing effective epitope-based vaccines and promising immunotherapies for many severe diseases. Due to extreme polymorphism of MHC-II alleles and the high cost of biochemical experiments, the development of computational methods for accurate prediction of binding peptides of MHC-II molecules, particularly for the ones with few or no experimental data, has become a topic of increasing interest. TEPITOPE is a well-used computational approach because of its good interpretability and relatively high performance. However, TEPITOPE can be applied to only 51 out of over 700 known HLA DR molecules. Method We have developed a new method, called TEPITOPEpan, by extrapolating from the binding specificities of HLA DR molecules characterized by TEPITOPE to those uncharacterized. First, each HLA-DR binding pocket is represented by amino acid residues that have close contact with the corresponding peptide binding core residues. Then the pocket similarity between two HLA-DR molecules is calculated as the sequence similarity of the residues. Finally, for an uncharacterized HLA-DR molecule, the binding specificity of each pocket is computed as a weighted average in pocket binding specificities over HLA-DR molecules characterized by TEPITOPE. Result The performance of TEPITOPEpan has been extensively evaluated using various data sets from different viewpoints: predicting MHC binding peptides, identifying HLA ligands and T-cell epitopes and recognizing binding cores. Among the four state-of-the-art competing pan-specific methods, for predicting binding specificities of unknown HLA-DR molecules, TEPITOPEpan was roughly the second best method next to NETMHCIIpan-2.0. Additionally, TEPITOPEpan achieved the best performance in recognizing binding cores. We further analyzed the motifs detected by TEPITOPEpan, examining the corresponding literature of immunology. Its online server and PSSMs therein are available at http://www.biokdd.fudan.edu.cn/Service/TEPITOPEpan/.

STMHCpan, an Accurate Star-Transformer-based Extensible Framework for Predicting MHC I Allele Binding Peptides.

PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity

MetaMHCpan, A Meta Approach for Pan-Specific MHC Peptide Binding Prediction.

Deep learning pan‐specific model for interpretable MHC‐I peptide binding prediction with improved attention mechanism

MHC2SKpan: a Novel Kernel Based Approach for Pan-Specific MHC Class II Peptide Binding Prediction

ACME: pan-specific peptide-MHC class I binding prediction through attention-based deep neural networks.

DeepMHCI: an anchor position-aware deep interaction model for accurate MHC-I peptide binding affinity prediction

NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

ACME: Pan-specific peptide-MHC class I binding prediction through attention-based deep neural networks

Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools.

MetaMHC: a meta approach to predict peptides binding to MHC molecules.

Ranking-based Convolutional Neural Network Models for Peptide-MHC Binding Prediction

TripHLApan: predicting HLA molecules binding peptides based on triple coding matrix and transfer learning

MATHLA: a robust framework for HLA-peptide binding prediction integrating bidirectional LSTM and multiple head attention mechanism

Deep Learning-Enhanced MHC-II Presentation Prediction and Peptidome Deconvolution

DeepSeqPan, a novel deep convolutional neural network model for pan-specific class I HLA-peptide binding affinity prediction

TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules

MHCII-peptide presentation: an assessment of the state-of-the-art prediction methods

DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity

Machine learning application to predict binding affinity between peptide containing non-canonical amino acids and HLA0201

ConvNeXt-MHC: improving MHC-peptide affinity prediction by structure-derived degenerate coding and the ConvNeXt model